Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Stemline Therapeutics Inc. STML

Healthcare Biotechnology
Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is involved in the business of discovering, acquiring and developing and commercializing therapeutics for oncology indications of unmet medical need. Its pipeline product candidates include felezonexor (SL-801, an XPO1 inhibitor), SL-1001 (a RET kinase inhibitor), SL-901 (a kinase inhibitor) and SL-701 (an... see more

Recent & Breaking News (NDAQ:STML)

Stemline Therapeutics to Present at the Wedbush Life Sciences Management Access Conference

GlobeNewswire August 5, 2014

Leading Health Care Stock for Small-Cap Stars is Arrowhead Research Corp (ARWR) for July 29

Equities.com July 29, 2014

PGT Inc. (PGTI) is the Top Small-Cap Star for July 29

Equities.com July 29, 2014

Stemline Therapeutics Announces Opening of SL-401 Corporate IND and Start of Clinical Trials in BPDCN and AML

GlobeNewswire July 28, 2014

Leading Health Care Stock for Small-Cap Stars is Inovio Pharmaceuticals Inc. (INO) for July 23

Equities.com July 23, 2014

Stemline Therapeutics to Present at the 2014 Wells Fargo Securities Healthcare Conference

GlobeNewswire June 10, 2014

Stemline Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

GlobeNewswire May 28, 2014

Stemline Therapeutics Announces Presentation of SL-401 Preclinical Efficacy Data in Multiple Myeloma at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire May 20, 2014

Stemline Therapeutics to Present at the Deutsche Bank 39th Annual Health Care Conference

GlobeNewswire April 30, 2014

Stemline Therapeutics Announces FDA Acceptance of IND for SL-701, a Synthetic Multi-Peptide Vaccine Targeting Glioma Brain Tumors

GlobeNewswire April 8, 2014

Stemline Therapeutics to Present at the 13th Annual Needham Healthcare Conference

GlobeNewswire April 7, 2014

Stemline Therapeutics Announces Presentation of SL-501 Preclinical Efficacy Data in TKI-Resistant CML at the Annual Meeting of the American Association of Cancer Research (AACR)

GlobeNewswire April 1, 2014

Stemline Therapeutics to Present at the 26th Annual ROTH Conference

GlobeNewswire March 6, 2014

Stemline Therapeutics to Present at Cowen and Company Health Care Conference

GlobeNewswire February 26, 2014

Stemline Therapeutics to Present at Citi 2014 Global Healthcare and RBC Capital Markets Conferences

GlobeNewswire February 20, 2014

Five Star Equities Issues New Research Reports on CGIX, OMED, STML and TTI

Accesswire February 12, 2014

Stemline Therapeutics to Present at the Leerink Global Healthcare Conference

Globe Newswire February 6, 2014

Stemline Therapeutics to Present at the 16th Annual BIO CEO & Investor Conference

Globe Newswire February 4, 2014

Five Star Equities Issues New Research Reports on CTIC, PACB, SEED and STML

Accesswire January 21, 2014

Stemline Therapeutics to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Globe Newswire January 7, 2014